| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024R372 | Non imprinted in Prader-Willi/Angelman syndrome 2, isoform CRA_a; | NIPA2; | NULL | 360 | human |
| A0A024R0J9 | Heterogeneous nuclear ribonucleoprotein U-like 1, isoform CRA_a; | HNRPUL1; | NULL | 756 | human |
| A0A024RB73 | HCG21937, isoform CRA_c; | NULL | NULL | 521 | human |
| A0A024R5F9 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 6, isoform CRA_a; | B3GNT6; | NULL | 415 | human |
| A0A024R0Y5 | 6-phosphofructokinase; EC 2.7.1.11; Phosphohexokinase; | PFKM; | NULL | 780 | human |
| A0A024R5I9 | Pyrimidinergic receptor P2Y, G-protein coupled, 6, isoform CRA_b; | P2RY6; | NULL | 328 | human |
| A0A024R6D8 | Splicing factor, arginine/serine-rich 5, isoform CRA_a; | SFRS5; | NULL | 272 | human |
| A0A024RBE7 | Thymopoietin, isoform CRA_c; | TMPO; | NULL | 454 | human |
| A0A080YUZ5 | Lysozyme A; Lysozyme-like 4; | LYZA; LYZL4; | NULL | 146 | human |
| Q9NZD9 | BM-018; TNFRSF21 protein; | TNFRSF21; | NULL | 124 | human |
| A0A024QYW7 | Pim-2 oncogene, isoform CRA_a; | PIM2; | NULL | 311 | human |
| A0A024R780 | Uncharacterized protein; | MGC5242; | NULL | 157 | human |
| A0A024R5G0 | Chromosome 11 open reading frame 51, isoform CRA_a; | C11orf51; | NULL | 121 | human |
| A0A024QZB5 | Uncharacterized protein; | MGC3121; | NULL | 585 | human |
| Q6ZWB5 | C3orf57 protein; Serine palmitoyltransferase small subunit B; cDNA FLJ41354 fis, clone BRAWH2014876; | C3orf57; SPTSSB; | NP_001035189.1; | 230 | human |
| A0A024R507 | Membrane-spanning 4-domains, subfamily A, member 1, isoform CRA_a; | MS4A1; | NULL | 297 | human |
| A0A024R897 | Actin-related protein 2/3 complex subunit 5; | ARPC5L; | NULL | 153 | human |
| A0A024R7K8 | Adaptor-related protein complex 1, mu 1 subunit, isoform CRA_a; | AP1M1; | NULL | 423 | human |
| A0A024QYW3 | Proteolipid protein 2 (Colonic epithelium-enriched), isoform CRA_a; | PLP2; | NULL | 152 | human |
| A0A024R9N3 | Transmembrane protein 85, isoform CRA_b; | TMEM85; | NULL | 183 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |